Clinical Trial Update: Raltegravir Therapy for Women With HIV and Fat Accumulation [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing raltegravir therapy for women with HIV and lipodystrophy; the study has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lipodystrophy

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: University of California, Los Angeles | Conditions: HIV Infections, Lipodystrophy | Phase 2 | Status: COMPLETED | Results posted: 2012-12-19